Literature DB >> 2542358

Seroepidemiology of human herpesvirus 6 infection in normal children and adults.

T Okuno1, K Takahashi, K Balachandra, K Shiraki, K Yamanishi, M Takahashi, K Baba.   

Abstract

Sera from normal subjects were examined for reactivity to human herpesvirus 6 (HHV-6) by the anticomplement immunofluorescence test. Of a total of 179 serum specimens from donors aged from under 10 to 59 years, 141 specimens showed positive reactivity against HHV-6. The positive rate was 70 to 83% for all age groups, and there were no substantial differences in the positive rates. Sera from younger children aged from 0 to 21 months were then examined in detail. The antibody-positive rate of children aged from 0 to 5 months decreased from 52 to 5%, but it gradually increased by 12 months. Almost all children had the antibody against this virus after 13 months of age.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542358      PMCID: PMC267390          DOI: 10.1128/jcm.27.4.651-653.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Characteristics of human herpesvirus-6.

Authors:  C Lopez; P Pellett; J Stewart; C Goldsmith; K Sanderlin; J Black; D Warfield; P Feorino
Journal:  J Infect Dis       Date:  1988-06       Impact factor: 5.226

2.  HBLV (or HHV-6) in human cell lines.

Authors:  D V Ablashi; S Z Salahuddin; S F Josephs; F Imam; P Lusso; R C Gallo; C Hung; J Lemp; P D Markham
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

3.  DNA homology between a novel human herpesvirus (HHV-6) and human cytomegalovirus.

Authors:  S Efstathiou; U A Gompels; M A Craxton; R W Honess; K Ward
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

4.  A novel lymphotropic herpesvirus.

Authors:  R S Tedder; M Briggs; C H Cameron; R Honess; D Robertson; H Whittle
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

5.  Isolation of human lymphotropic herpesviruses from Uganda.

Authors:  R G Downing; N Sewankambo; D Serwadda; R Honess; D Crawford; R Jarrett; B E Griffin
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

6.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

7.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

  7 in total
  103 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Infection and infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

3.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

4.  HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.

Authors:  Danielle M Zerr; Michael Boeckh; Colleen Delaney; Paul J Martin; Hu Xie; Amanda L Adler; Meei-Li Huang; Lawrence Corey; Wendy M Leisenring
Journal:  Biol Blood Marrow Transplant       Date:  2012-05-26       Impact factor: 5.742

5.  Complementation of the function of glycoprotein H of human herpesvirus 6 variant A by glycoprotein H of variant B in the virus life cycle.

Authors:  Hiroko Oyaizu; Huamin Tang; Megumi Ota; Nobuyuki Takenaka; Keiichi Ozono; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

6.  Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

Authors:  E C Schirmer; L S Wyatt; K Yamanishi; W J Rodriguez; N Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

7.  gp96 Is Critical for both Human Herpesvirus 6A (HHV-6A) and HHV-6B Infections.

Authors:  Jingjing Ma; Junli Jia; Xuefeng Jiang; Mengyuan Xu; Jinfeng Guo; Tian Tang; Xianyi Xu; Zhisheng Wu; Benshun Hu; Kun Yao; Lingyun Li; Huamin Tang
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

8.  Detection by polymerase chain reaction amplification of human herpesvirus 6 DNA in peripheral blood of patients with exanthem subitum.

Authors:  K Kondo; Y Hayakawa; H Mori; S Sato; T Kondo; K Takahashi; Y Minamishima; M Takahashi; K Yamanishi
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

9.  Clinical manifestations associated with human herpesvirus 7 infection.

Authors:  S Torigoe; T Kumamoto; W Koide; K Taya; K Yamanishi
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

10.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.